Akso Health Group ADS (AHG)
FairStock Score: 25/100 — RISKY
Key Financials
| Current Price | $1.3 |
| Market Cap | $1.8B |
| P/E Ratio | -43.33 |
| ROE | -9.85% |
| Dividend Yield | —% |
| Sector | Healthcare |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I look for a business I can understand, with durable economics and a price that leaves a margin of safety. Akso Health Group is a social e-commerce mobile platform in China, operating Xiaobai Maimai and selling goods from food and wine to cosmetics and home appliances, plus medical devices. At $1.36 on 2026-10-13, the market values it at $1.8B. The numbers I have are not comforting. The supplied FairStock P/E is -45.30, P/B is 6.47, ROE is -9.85%, and ROCE is -1.24%. Those are calculations from the supplied data, but they point to a money-losing enterprise selling well above book value. The supplied Piotroski F-Score is 2/9, and FairStock Score is 25/100. The Altman Z-Score of 121.39 and D/E of 0.01 suggest low leverage and little measured bankruptcy risk, which is a real positive. Yet revenue growth and profit growth are N/A, and FairStock's Lynch category is 'none' because there are only 0 years of filed annual results, needing 3. With 12 employees and a competitive Chinese e-commerce and healthcare distribution niche, I see no evidence of a moat. The 52-week range of $0.68-$2.50 shows volatility, and beta of -1.07 is unusual. I cannot underwrite growth or normalized earning power. Without a multi-year record, this looks speculative rather than an investment-grade value opportunity.
In plain English: Akso Health Group runs a social shopping app in China and also sells medical devices. The given figures show it is losing money, and the share price looks high compared with the value of its assets. It has very little debt, but there is not enough filed history to judge the business, and its overall quality score is low.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer